Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;135(Suppl 1):195-200.
doi: 10.1007/s00508-022-02119-7. Epub 2023 Apr 20.

[Diagnosis, treatment and monitoring of diabetic eye disease (Update 2023)]

[Article in German]
Andreas Pollreisz  1 , Vanessa Gasser-Steiner  2 , Bianca Gerendas  3 , Stefan Mennel  4 , Stephan Radda  5 , Stefan Sacu  3 , Christoph Scholda  3 , Ulrike Stolba  6 , Andreas Wedrich  7 ; Netzhautkommission der Österreichischen Ophthalmologischen Gesellschaft
Affiliations

[Diagnosis, treatment and monitoring of diabetic eye disease (Update 2023)]

[Article in German]
Andreas Pollreisz et al. Wien Klin Wochenschr. 2023 Jan.

Abstract
in English, German

Diabetes mellitus can cause diabetic retinopathy, diabetic macular edema, optic neuropathy, cataract or dysfunction of the eye muscles. The incidence of these disorders correlates with disease duration and quality of metabolic control. Regular ophthalmological examinations are needed to prevent sight-threatening advanced stages of diabetic eye diseases.

Diabetes mellitus kann zu unterschiedlichen Augenerkrankungen führen, wie diabetische Retinopathie, diabetisches Makulaödem, Optikusneuropathie, Katarakt, Sekundärglaukom und Fehlfunktionen der äußeren Augenmuskeln. Die Inzidenz dieser Spätschäden korreliert mit der Dauer des Diabetes und mit dem Grad der metabolischen Kontrolle. Reguläre augenfachärztliche Kontrollen sind notwendig, um visusbedrohende Spätschäden einer diabetischen Augenerkrankung frühzeitig zu erkennen und entsprechende Therapien einzuleiten.

Keywords: Diabetic macular edema; Diabetic retinopathy; Intravitreal drug delivery; Retinal laser photocoagulation; Vitrectomy.

PubMed Disclaimer

References

    1. Flaxel CJ, et al. Diabetic retinopathy preferred practice pattern(R) Ophthalmology. 2020;127:P66–P145. doi: 10.1016/j.ophtha.2019.09.025. - DOI - PubMed
    1. Hammes HP, Lemmen KD, Bertram B. Diabetic retinopathy and maculopathy. Exp Clin Endocrinol Diabetes. 2021;129:S64–S69. doi: 10.1055/a-1284-6223. - DOI - PubMed
    1. Solomon SD, et al. Diabetic retinopathy: a position statement by the American diabetes association. Diabetes Care. 2017;40:412–418. doi: 10.2337/dc16-2641. - DOI - PMC - PubMed
    1. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875–1891. doi: 10.2337/diacare.15.12.1875. - DOI - PubMed
    1. Cosentino F, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323. doi: 10.1093/eurheartj/ehz486. - DOI - PubMed

Publication types